На главную
Результаты поиска “U.S. Pharmaceutical Sales Statistics” за 2018
The USA Has 5% Of The Worlds Population And Uses 70% Of The World's Pharmaceuticals
 
10:47
On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen  offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned firsthand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. Connect with The Real Truth About Health http://www.therealtruthabouthealth.com/ https://www.facebook.com/The-Real-Truth-About-Health-467500836655781/ https://twitter.com/RTAHealth Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO's. Fighting to stop climate change and extinction.
Просмотров: 615 The Real Truth About Health
The Fines That Pharmaceutical Companies Have Paid with Gwen Olsen
 
06:00
On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned firsthand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. Connect with The Real Truth About Health http://www.therealtruthabouthealth.com/ https://www.facebook.com/The-Real-Truth-About-Health-467500836655781/ https://twitter.com/RTAHealth Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO's. Fighting to stop climate change and extinction.
Просмотров: 326 The Real Truth About Health
Halftime Report | Will 2019 be the Year of Reckoning for Sun Pharmaceuticals? | CNBC TV18
 
15:42
A glance at the Nifty Pharma index shows the wealth erosion in pharmaceutical companies has been steep. The Nifty Pharma index has lost 14% in 2018 and over 20% in the past two years with bigwig stocks such as Sun Pharmaceuticals not too far from these statistics. Sun Pharma has lost 14% of its market cap with an over 30% loss in the past two years. Like the sector, the main reasons for Sun’s underperformance is mainly two fold. CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise. Subscribe to our Channel: https://goo.gl/hKwgtm Like us on Facebook: https://www.facebook.com/cnbctv18india/ Follow us on Twitter: https://twitter.com/CNBCTV18News Website: http://www.moneycontrol.com/cnbctv18/
Просмотров: 483 CNBC-TV18
How To Find The Best Price For Your Flu Meds | NBC Nightly News
 
01:48
NBC News’ Gabe Gutierrez explains why the price of Tamiflu has more than doubled over the last decade, and ways that you can get it for less. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, Meet The Press, and original digital videos. Subscribe to our channel for news stories, technology, politics, health, entertainment, science, business, and exclusive NBC investigations. Connect with NBC News Online! Visit NBCNews.Com: http://nbcnews.to/ReadNBC Find NBC News on Facebook: http://nbcnews.to/LikeNBC Follow NBC News on Twitter: http://nbcnews.to/FollowNBC Follow NBC News on Google+: http://nbcnews.to/PlusNBC Follow NBC News on Instagram: http://nbcnews.to/InstaNBC Follow NBC News on Pinterest: http://nbcnews.to/PinNBC How To Find The Best Price For Your Flu Meds | NBC Nightly News
Просмотров: 543 NBC News
What is EPSYCHOLOGY? What does EPSYCHOLOGY mean? EPSYCHOLOGY meaning, definition & explanation
 
03:39
What is EPSYCHOLOGY? What does EPSYCHOLOGY mean? EPSYCHOLOGY meaning - EPSYCHOLOGY definition - EPSYCHOLOGY explanation. Source: Wikipedia.org article, adapted under https://creativecommons.org/licenses/by-sa/3.0/ license. SUBSCRIBE to our Google Earth flights channel - https://www.youtube.com/channel/UC6UuCPh7GrXznZi0Hz2YQnQ Epsychology is a form of psychological intervention delivered via information and communication technology. epsychology interventions have most commonly been applied in areas of health; examples are depression, adherence to medication, and smoking cessation. Future applications of epsychology interventions are likely to become increasingly more common in information, organization, and management sciences (e.g. organizational change, conflict management and negotiation skills). Recently, several meta-analyses have documented the effects of epsychology interventions. In general, it appears that intensive theory-based interventions that include multiple behaviour change techniques and modes of delivery (e.g. mobile phones and the Internet) are the most effective. More specifically, interventions based on the theory of planned behaviour and cognitive-behavioural therapy seem to provide the most promising results. These findings should, however, be interpreted with caution as many research articles fail to report the theoretical underpinnings of epsychology interventions adequately. Lifestyle and non-communicable diseases, such as excessive alcohol consumption, depression, and physical inactivity, are the leading causes of morbidity and premature mortality. Thus, there is a great potential for utilizing epsychology to reach out and deliver prevention and treatment to the public by means of information technology. Information technology has a high scalability and given the usage and population statistics on, for example, Internet technology, researchers argue that we simply cannot afford to ignore information technology as a viable approach to public health. Among the first companies to take advantage of the new technological opportunities combined with state-of-the-art psychological research were Health Media in the US (later acquired by Johnson & Johnson) and the privately held Changetech AS in Norway. Epsychology interventions are considered a supplement to existing treatments rather than a substitute, although such interventions can be used as a stand-alone treatment given that they are more cost-effective than standard treatment. Pharmaceutical companies Janssen-Cilag and Novartis were also early out with patient-support programs that came with the patients' medication. The purpose in such programs is primarily to help patients take their medication as prescribed. A lack of medical compliance is a serious health problem even among patients diagnosed with severe and potentially fatal diseases such as cancer or HIV/AIDS. In fact, in one study about 70% of hospital visits for adverse drug reactions were caused by inadequate medical compliance. Although patient-support programs may lack in theoretical orientation, it is clear that they try to help patients manage an inherent psychological problem.
Просмотров: 6 The Audiopedia
3 STOCKS TO BUY APRIL 2018
 
09:41
3 Stocks to Buy in April 2018 is a popular series on this channel. I cover stocks to watch, buy, invest in April 2018! These are 3 stocks you can buy today, and hold forever on the dip as they are currently presenting great opportunities for entries. The 3 picks for this month are Nvidia Stock, Facebook Stock, and Home Depot Stock. All 3 of these companies have had a great 2017, and have recently been experiencing some turbulence but I believe they will make a good recovery in 2018. 1) Nvidia Stock Analysis NVDA These guys are just a profit machine and growth machine and they keep posting outstanding numbers and show no signs of slowing down. The last month or so as the market has been a bit weak and volatile, NVDA has kind stood its ground. Everytime it sells off, buyers come back in to push it higher. This stock is really outperforming the market right now, and is showing similar strength as AMZN and NFLX as well. In march, we had 2 analysts come out and reiterate their view on NVDA this month. Both have targets that are a lot higher than the current share price and it's clear analysts are also very bullish on NVDA's future. If you want to see my technical analysis and view on Nvidia, check out the video. 2) Facebook Stock Analysis FB You guys already know my stance on FB - this is a stock I personally hold in my long term portfolio, and it's a company that just keeps growing. They own FB, Insta, and WHatsapp, and they have over 2B users on these platforms. Celebs are switching from Snap to Insta, which is where I think FB will be seeing a lot of $ coming in from. The selloff imo was unwarranted - I gave my reasoning in this video so check it out if you're unsure. I believe FB will recover this year - but April in a great time to scoop up more shares in this company. It might be a slower recovery than we're used to, but as long as their earnings and growth continue, it should be back to ATH this year. In march there was only 1 analyst who came out and reiterated their stance on Facebook. If you want to see my technical analysis and view on Nvidia, check out the video. 3) Home Depot Stock Analysis HD HD - of course a home improvement store, the largest in this space in North America - and their only true competitor is Lowes - who is far behind. Morgan Stanley said the recent weakness has created a "compelling entry point" for investors. You shouldn't believe what these Analysts say, but you should pay attention to the general sentiment. Nothing has fundamentally changed in HD and they are still strong, and MS recognizes that. There are fears out there that interest rate hikes may affect home sales and renovation sales - but this is something we'll have to wait and see about. We did have hikes in the past, and home sales just kept rising QoQ, so if the last few years tells us anything, it's that people want to buy houses! In March, Loop Capital initiated coverage on HD. If you want to see my technical analysis and view on Nvidia, check out the video. Thank you for watching! Don't forget to LIKE, COMMENT and SUBSCRIBE if you haven't done so already to support the channel - it means a lot to me! Let me know what videos you would like me to cover in the future. Either way, remember to invest positively. Peace! Disclaimer: None of the stocks, options, or securities that I discuss should be taken as advice or recommendations to buy/sell/hold as I am not a financial adviser. The views and information presented in these videos is strictly for educational purposes and I will not be held liable for your gains or losses incurred due to trading, investing, or getting involved in the stock market. Follow me on Twitter: https://goo.gl/w4xsnl Follow me on Instagram: https://goo.gl/fW5rYn Equipment used for videos: Microphone: http://amzn.to/2zVpWGz Lighting Kit: http://amzn.to/2EVbL8t Camera: http://amzn.to/2HPaqgT Laptop for Editing: http://amzn.to/2EUbORQ
Просмотров: 3276 Positive Investing
Retail Industry: Digital Transformation, Customer Experience, and Innovation (CXOTalk #282)
 
48:56
How is the retail industry changing and innovating? How about the role of customer experience and change agents? For more information and to read the complete transcript, see https://www.cxotalk.com/episode/digital-transformation-retail-innovation-changes Dana Randall, head of innovation at Tapestry, speaks with CXOTalk and guest co-host Brian Solis about digital transformation in retail businesses. The company, which includes the brands Coach and Kate Spade, is rethinking traditional sales and adapting to shifts in social, cultural, technology and consumer expectations. Dana Randall is the Head of Innovation at Tapestry, helping to drive innovation in retail through strategic partnerships with technology companies and startups. She has been listed by Digiday in The Glossy 50 recognizing the leaders creating change in fashion, luxury, beauty, and tech, as well as named as one of Brand Innovators 40 Under 40 & Women to Watch.
Просмотров: 5994 CXOTALK
Pharmacies Email List Providers
 
01:12
The pharmaceutical sector is evergreen and the demand for medical supplies and pharmaceuticals never diminishes. Pharmacists may work at community pharmacies, hospitals and primary care organizations. The affordable Pharmacy email list is ideal for effective promotion and sale of medical offerings. It ensures that marketing messages reach genuine audience globally. Pharmacists were seen practicing across hospitals, mail-order pharmacies, retail pharmacies, Federal government, clinics, home healthcare agencies etc. So how about engaging with them with your medical offerings? Their numbers are extensive, but with the pharmacist email lists from Top Healthcare Leads, the route to reaching out to them can be effortless. Our active, influential, responsive list of pharmacies that is absolutely perfect for your promotion. As a vital source of sales and marketing solutions, Global B2B Contacts pharmacist email lists enable you to establish and maintain business relationships; generate new business and market more effectively and efficiently. As marketing list providers we believe in continuous improvement of our services. Since our audiences play a significant role in our business success we ensure that when we develop the pharmacist database we align it to their business needs. With data like name, title, mailing address, phone numbers, email addresses, specialty, hospital affiliation, UPIN number etc. our pharmacists mailing lists is a proven way to reach audiences as per preferred channels of communication. Whether you’re trying to reach independents or national chains, you can target decision makers at every level. The best part is every name in the pharmacist database connects to each contact’s email address, site address, phone and fax number, and other profiling data Our active and regularly updated pharmacy mailing list covers all US pharmacies for effective market penetration and enticing business growth. Take business campaigns to the next level with the valid Pharmacies email address lists. Are you willing to reach the Pharmacies for your marketing and sales efforts? Our well researched Pharmacies Email database could be at your serve. We can customize the Contact Lists based on specialty, geography, organization size, and various other selection criteria’s so that you could directly reach the right in-boxes to meet your attainment. https://www.globalb2bcontacts.com/pharmacies-email-list.html
Просмотров: 18 Global B2B Contacts LLC
Matching your resume with LinkedIn
 
01:36
A short video about making sure your LinkedIn profile matches your resume, in particular the dates. It causes major alarm bells with employers if the dates aren't matching. If you've applied directly with a company the chances of them calling you to double check are very slim so it is vitally important that you take time to make sure your profile is up to date. I've witnessed clients dismiss applicants on the back of dates not matching or if a candidates has missed a company on a resume but it can be seen on LinkedIn and vice versa. Even if you are trying to remember dates from 6, 7 or 8 years plus back, giving a rough estimate of the month is fine but make sure they match anywhere the company is checking, in particular LinkedIn. #recruitment #linkedin Visit our website www.verumassociates.com.au Contact us on 02 8006 0862 or email info@verumassociates.com.au Follow us on Social Media: Twitter:- www.twitter.com/verumassociates LinkedIn:- www.linkedin.com/company/verum-associates-ltd Facebook:- https://www.facebook.com/verumassocia... Instagram:- https://www.instagram.com/verumassoci... Verum Associates PTY Ltd are the only Sydney based recruiter that is solely dedicated to technology sales. We assist the technology industry to ensure the most competent sales talent is placed in the right organisation to help both bottom line and career aspirations. Our client base encompasses numerous technology stacks such as SaaS, Cloud, Infrastructure, Datacentre, Enterprise Software, Communications, and we enjoy a focus on new trends and innovations that are changing the industry. Technology sales recruitment is our speciality, meaning we can offer more than just a one level recruitment service; we offer up-to-date industry news, market trends, salary advice and interview preparation. We know the days of solely relying on one platform to produce results are long gone, and that the top talent don’t actively look for their new positions with high-street recruiters. We have a presence across all social media networks, relationships with industry bodies and influencers, allowing us to attract and introduce the right talent to their next challenge. Verum Associates recruit all roles relating to technology sales inclusive, but not limited to, the following: • Business development manager • Account manager • Account director • Territory manager • Channel manager • Presales consultant • Sales consultant • Sales representative • Product manager • Sales manager • Sales director Speak to us in confidence and with no obligation, we would be delighted to explain (and ideally demonstrate) how we operate.
Просмотров: 3 Verum Associates PTY Ltd
PPCChamp Client Review - "We Made over 3.5 Crore in Sales" -  Sahil Sharma MD at JM Healthcare
 
01:56
Sahil Sharma is the Director of JM Healthcare Pvt. Ltd. - A Reputed Third Party Pharma Manufacturing Company based in Chandigarh. In this video one of our Clients Mr Sahil Sharma shared his words of appreciation with us after we successfully delivered digital marketing services. Looking for the Best Digital Marketing Agency in India for your business then look no further than PPCChamp as we can help you with all your Digital Marketing, Social Media Marketing, SEO related activities etc. Contact Details: PPCChamp – Digital Marketing Company Address: Building Number- 54-55, Sector 34 A Chandigarh India -160022 Phone Number: +91-9501488575, +91-9878873077 Email: Info@ppcchamp.com Website: http://www.ppcchamp.in/ Skype: PPC.Champ
Просмотров: 158 PPCChamp Digital Marketing Company
Porter's five forces analysis of Google
 
05:04
-- Created using PowToon -- Free sign up at http://www.powtoon.com/youtube/ -- Create animated videos and animated presentations for free. PowToon is a free tool that allows you to develop cool animated clips and animated presentations for your website, office meeting, sales pitch, nonprofit fundraiser, product launch, video resume, or anything else you could use an animated explainer video. PowToon's animation templates help you create animated presentations and animated explainer videos from scratch. Anyone can produce awesome animations quickly with PowToon, without the cost or hassle other professional animation services require.
Просмотров: 72 Farkhod Karimjonov
How Much Do Medical Aesthetics Make?
 
01:00
Medical esthetician salaries by education, experience, location and how much do medical aestheticians make? Outstanding collegesnational laser institute. What makes medical esthetics unique is that it performed on patients in a clinical their duties may include providing skin treatments, teaching make up techniques and giving chemical peels. What is the average annual salary for medical esthetician? How much does a esthetician make? The median as of march 01, 2018, with range usually between however this can vary widely depending on variety factors 13 mar 2018 2 careers in aesthetics; 3 how to become nurse esthetician; 4 do estheticians make per hour? Estheticians, also known aestheticians and skin care specialists, are personal appearance professionals who focus facial body care, makeup artistry, hair removal skincare specialists earned 2016, according u. I will be takig medical esthetics this june, and hope to done by december. Medical aesthetics products specialty and brand pharmaceutical. How much does a medical esthetician earn? Youtube. Very often, medical aestheticians work with individuals that have skin damaged by trauma, disease or a procedure gone wrong. The job of a medical esthetician is to become esthetician, you should first look at taking program an esthetics school. Dec 2015 medical aesthetics doesn't focus on conditions the field is entirely focused helping people look and feel better. According to the bureau of labor statistics, skincare specialists earn an average salary per year medical esthetician salaries. What are my job prospects? Does anyone know how much i could make as an esthetician working for a plastic surgeon? Was this comment of mar 2018, the average pay licensed medical aesthetician is $16. What is an esthetician? Us news money us & world report. Googleusercontent search. One should expect to devote at 15 feb 2015 can an aesthetic doctor carry out a breast enlargement operation? What about plastic surgeons, what do they do? What's the role of dermatologists in all this? As far as i remember, there're always couple standard questions that get asked when meeting new acquaintance party dec 2017 buzzydoc is there help medical practices win more patients and increase sales without creating work for staff aesthetics operates under direction supervision dr. Son the low end, skincare specialists earned a 25th percentile salary of meaning 75 percent more than this amount. Aesthetic nurse salary how much money can you earn as an medical aesthetician job shadow. Thanks to the many scientific advances in medicine over last century, people are living longer, healthier lives. How much does it cost to train as an aesthetic nurse? Box navigation 05 a registered nurse, you must undertake foundation course in botox and dermal fillers minimum training requirement before start practising nurse. Medical aesthetician jobs what is a medical esthetician's salary? Certified aesthetics certification and career learn. Usually, medical aest
Просмотров: 14 new sparky
Nas Claims 12th Top 10 Album on Billboard 200 Chart With 'Nasir'
 
02:41
Nas Claims 12th Top 10 Album on Billboard 200 Chart With 'Nasir' Nas is back on the Billboard 200 albums chart, as his new Nasir set starts at No. 5, granting the hip-hop star his 12th top 10 effort. Nasir — released on June 15 via Mass Appeal/Def Jam Recordings — launches with 77,000 equivalent album units earned in the week ending June 21, according to Nielsen Music. Of that sum, 49,000 were in traditional album sales. The Billboard 200 chart ranks the most popular albums of the week in the U.S. based on multi-metric consumption, which includes traditional ...
Просмотров: 60 SS NEWS
Arteric Answers: How do you foster innovation in a pharmaceutical marketing organization?
 
12:49
Hans Kaspersetz answers: "How do you foster innovation in medical device and pharmaceutical marketing organizations?" Then provides three examples of how Arteric fosters innovation.
Просмотров: 31 Arteric
Katherine Eban: The Helpless U.S. in the Global Pervasiveness of Fraudulent Drugs on The Open Mind
 
27:38
Investigative reporter Katherine Eban joins us on The Open Mind to shed light on her findings surrounding pharmaceutical counterfeiting. Eban uncovered the comprehensive picture of how under-policed generic companies operate for Fortune Magazine. As she writes, “It’s not a tale of cutting corners or lax manufacturing practices, but one of outright fraud in which the company knowingly sells substandard drugs around the world including in the US, while working to deceive regulators.” Watch on PBS: http://www.pbs.org/show/open-mind/ Watch on Thirteen.org: https://www.thirteen.org/openmind/science/the-real-drug-crisis/5943/ Follow The Open Mind on Twitter: https://twitter.com/OpenMindTV Follow Katherine Eban on Twitter: https://twitter.com/KatherineEban Follow Alexander Heffner on Twitter: https://twitter.com/heffnera In this episode of The Open Mind, we discuss how the high cost of medication in the United States has led us into the arms of foreign powers to produce low-cost generic drugs. Big Pharma companies have become experts in how to fraudulently market drugs and alter data in manufacturing labs. Yet, top executives are not put in jail. The FDA, originally set up as a domestic agency, finds itself tasked with becoming a global policeman of foreign manufacturing plants. Ill-equipped for this responsibility, overseas manufacturing plants often end up fooling the FDA to gain approval for drugs that don’t actually work. While the impact on patients will likely never be known, it’s clear that millions of people worldwide got medicine of dubious quality. What do we need to do to start tackling worldwide drug counterfeiting? Eban argues that the United States can start by regulating drug prices to take some of the profit and heat out of the pharma marketplace, releasing us from the arms of low-cost drug makers in developing countries like India and China. Bringing drug production back to the United States can be pricey, but Eban believes we are a couple of scandals away from widespread awareness in terms of drug pricing. Eban suggests that we need a consumer revolution to spark change, and stresses the importance of remaining persistent throughout our unusual news cycles, holding onto and pushing through important issues.
Просмотров: 8392 The Open Mind
Trends in Indian Personal Care Industry
 
47:02
The talk is delivered by Mr. Jayesh Vithalani, Business Director - Personal & Home Care - South Asia Middle East, Lubrizol Advanced Materials India Pvt Ltd. At Indian Home & Personal Care Industry Market Opportunities & Challenges conference on Wednesday April 25 alongside Chemspec India / HPIC India (25-26 April 2018), Hall 1, Bombay Exhibition Centre, Mumbai. To stay tuned with further updates connect with us on: Linkedin: http://www.linkedin.com/in/chemspecindia Twitter: https://twitter.com/chemspecindia18 @chemspecindia18 Facebook: http://www.facebook.com/ChemspecIndia Website: http://www.chemspecindia.com, http://www.chemlogisticsindia.com Next Chemspec India will take place from 16-17 April 2019 at the Bombay Exhibition Centre, Mumbai. About the exhibition: Over the past decade and a half, Chemspec India has continued to develop and reinforce itself as the must-attend networking platform for both domestic and international buyers and sellers of Fine and Speciality Chemicals. Participating companies at Chemspec India represent diverse sectors of the chemical industry: Organic & Fine Chemicals, Active Pharmaceutical Ingredients (APIs), Drug Intermediates, Dyes & Pigments, Agrochemicals, Contract & Toll Manufacturing, Coatings, Cosmetic Chemicals / Ingredients, Pigments & Solvents, Surfactants, Laboratory Chemicals, and a host of Speciality Chemicals (Coating Additives, Catalysts, Enzymes etc.). It will also see a focus on Water Treatment Chemicals and the Wastewater Treatment Industry. 15th edition of Chemspec India will take place along three other co-located events. ChemProTech India 2019 – 10th International Exhibition for Chemical Processing Technology, Equipment and Supplies ChemLogistics India 2019 - 5th International Exhibition on Chemical Warehousing, Transport & Logistics HPIC India 2019 - 4th International Exhibition on Ingredients for Home, Personal & Institutional Care
Просмотров: 21 Chemspec India
Greenville County sues pharmaceutical companies
 
03:05
Greenville County sues pharmaceutical companies.
Просмотров: 39 WSPA 7News
Breaking News  - Profit from the Made in Britain boom
 
08:23
Britain may not be the industrial giant it once was, but our factories are thriving.Manufacturing output has risen for the past eight months, marking the longest run of expansion for nearly 30 years and confounding predictions of decline.Overall, factory output rose by 2.3 per cent  in the last three months of 2017, according to the Office for National Statistics.So how can you take advantage of the revival to give your Isa a boost?Britain's pharmaceutical sector is booming and is home to some of the world's biggest drug companies.The sector employs more than 61,500 people and exports nearly £30 billion of medicines each year, according to the European Federation of Pharmaceutical Industries and Associations.In December, drug-makers were the second-fastest growing area of British manufacturing, according to the ONS.For savers wanting to profit, Darius McDermott, of fund supermarket Chelsea Financial Services, tips Threadneedle UK Equity Alpha Income.It invests nearly £13 in every £100 of your cash in drugs giants AstraZeneca and GlaxoSmithKline.Cambridge-based AstraZeneca, which rebuffed a £70 billion takeover bid from US rival Pfizer in 2014, was given a boost this week by the U.S. drug regulator's decision to grant approval to one of its key new cancer medicines.The Food and Drug Administration approved Imfinzi for treating stage three lung cancer patients who have had chemotherapy and radiotherapy.Analysts believe the move could be worth up to $2 billion (£1.4 billion) in annual sales to Astra, which employs 6,700 people at seven sites in the UK.This month, GlaxoSmithKline reported a 3 per cent rise in annual turnover to £30.2 billion, with profits rising 5 per cent to £8.5 billion.It is hopeful new treatments for lung conditions, HIV and shingles will help it continue to grow. It employs 16,000 people at 18 UK sites.Threadneedle UK Equity Alpha Income has turned £10,000 into £14,904 in five years.Britain's food, drink and tobacco manufacturers are also growing strongly, up 0.9 per cent in December, according to figures.Food and drink is the UK's biggest manufacturing sector, employing more than 400,000 people and generating more than £112 billion for the economy, according to trade body Food & Drink Federation.Ben Yearsley, of adviser Shore Financial Planning, believes Troy Trojan Income is one of the best ways to profit from the sector and resurgence of manufacturing as a whole.The second biggest holding in the fund, which has turned £10,000 into £14,727 in five years, is Unilever, which makes a range of foods such as Flora margarine, Hellman's mayonnaise as well as household brands such as Dove.It claims its products are in around 98 per cent of UK homes and used by two billion people globally each day.The London-based firm, has three UK research centres and multiple factories. Its share price has risen 41 per cent in five years, and it is the world's second largest advertising spender.Mr Yearsley says: 'Despite all of the doom and gloom ab AutoNews- Source: http://www.dailymail.co.uk/money/investing/article-5414683/Profit-Britain-boom.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490
Просмотров: 3 US Sciencetech
Industry News: Roche Buys Flatiron
 
05:56
Industry News: Roche Buys Flatiron The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D. Flatiron’s cancer-centric electronic health records platform is linked to some 250 community oncology practices; it has a partnership with the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to improve clinical trials by gathering data at the point of care. What’s made the company appealing to venture capital outfits, the drug industry, and the government is that Flatiron doesn’t just suck in a bunch of numbers and spit them out—its datasets are curated in an effort to separate statistical noise from actionable information. That’s hard to pull off on a mass scale. - From Fortune.com Don't forget to Subscribe for new content! Email: eliteclinicalgroup@gmail.com We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education ------------------------------------------------------------------------------------------------------------ Elite Clinical Research Group or ECRG for short is a content creating conglomerate that offers many services to individuals in the clinical research and pharmaceutical space. We always keep our "Why" of improving patients lives in mind with everything we do and are always looking to partner with people that are of like mind. Clinical Research is one of the hottest fields in the world right now and thousands of college graduates, masters candidates and phd graduates are looking to enter the clinical research world. Reach out by comment or email if we can help in any way. -~-~~-~~~-~~-~- Please watch: "Should I Be A Data Manager or TMF Specialist?" https://www.youtube.com/watch?v=4Ok7Ii6BV-U -~-~~-~~~-~~-~-
Просмотров: 152 Elite Clinical Research
Hedge Fund Manager Jeremy Grantham- Quant Trader with Event Driven Strategies
 
02:34
Jeremy Grantham is a British investor and co-founder and chief investment strategist of Grantham, Mayo, & van Otterloo (GMO), a Boston-based asset management firm. GMO is one of the largest managers of such funds in the world, having more than US$118 billion in assets under management as of March 2015. Grantham is regarded as a highly knowledgeable investor in various stock, bond, and commodity markets, and is particularly noted for his prediction of various bubbles. Event-driven strategies concern situations in which the underlying investment opportunity and risk are associated with an event. An event-driven investment strategy finds investment opportunities in corporate transactional events such as consolidations, acquisitions, recapitalizations, bankruptcies, and liquidations. Managers employing such a strategy capitalize on valuation inconsistencies in the market before or after such events, and take a position based on the predicted movement of the security or securities in question. Large institutional investors such as hedge funds are more likely to pursue event-driven investing strategies than traditional equity investors because they have the expertise and resources to analyze corporate transactional events for investment opportunities. Corporate transactional events generally fit into three categories: distressed securities, risk arbitrage, and special situations. Distressed securities include such events as restructurings, recapitalizations, and bankruptcies. A distressed securities investment strategy involves investing in the bonds or loans of companies facing bankruptcy or severe financial distress, when these bonds or loans are being traded at a discount to their value. Hedge fund managers pursuing the distressed debt investment strategy aim to capitalize on depressed bond prices. Hedge funds purchasing distressed debt may prevent those companies from going bankrupt, as such an acquisition deters foreclosure by banks. While event-driven investing in general tends to thrive during a bull market, distressed investing works best during a bear market. Risk arbitrage or merger arbitrage includes such events as mergers, acquisitions, liquidations, and hostile takeovers.[66] Risk arbitrage typically involves buying and selling the stocks of two or more merging companies to take advantage of market discrepancies between acquisition price and stock price. The risk element arises from the possibility that the merger or acquisition will not go ahead as planned; hedge fund managers will use research and analysis to determine if the event will take place. Special situations are events that impact the value of a company's stock, including the restructuring of a company or corporate transactions including spin-offs, share-buy-backs, security issuance/repurchase, asset sales, or other catalyst-oriented situations. To take advantage of special situations the hedge fund manager must identify an upcoming event that will increase or decrease the value of the company's equity and equity-related instruments. Other event-driven strategies include: credit arbitrage strategies, which focus on corporate fixed income securities; an activist strategy, where the fund takes large positions in companies and uses the ownership to participate in the management; a strategy based on predicting the final approval of new pharmaceutical drugs; and legal catalyst strategy, which specializes in companies involved in major lawsuits. FAIR USE NOTICE: This channel may make use of copyrighted material. This channel gains no profit from broadcasted content. In accordance with Title 17 U.S.C. Section 107, the material on this channel is offered publicly and without profit, to the public users of the internet for comment, non-profit, educational, and informational purpose. No copyright is claimed. This content is being posted here for financial educational purposes, so that investors will have a better understanding of financial markets.
Просмотров: 1206 scottab140
My #1 Favorite Dividend Stock of All Time (If I Could Only Own 1 Dividend Stock)
 
25:47
Several subscribers recently asked about my favorite dividend growth stock of all time. Specifically, they asked which dividend stock I would own if I had to place all of my investment funds in one single stock. My answer is quite simple, as Johnson & Johnson (ticker: JNJ) is already the largest position in my portfolio. Today's video explains why Johnson & Johnson is my favorite stock for dividends, complete with fundamental analysis. I get started with some high level thoughts. Why do I like this stock so much? It really comes down to some high level concepts including: * Predictability (and stability) * Incredible margins (gross profit and operating) * Population trends (aging US population and growing global population) * More! Next, I dive into my Johnson & Johnson fundamental stock analysis. Specifically, I discuss concepts including: * Revenue Growth: I really enjoy how revenue is up 25% comparing 2007 and 2017. I also like how revenue tends to grow predictably on a year-by-year basis. It's like clockwork. * US versus international mix. International sales are getting close to representing 50% of this company's mix. * Incredible Margins: Gross profit is at 66.8% (wow!) and operating profit is at 23% (both from the 2017 annual report). * Dividend growth: I invest for passive income and cash flow! I need to buy companies to put cash in my pocket, cash that can be used to pay the bills. Johson & Johnson is a great example, as they've raised their dividend over 105% comparing 2017 to 2007. Despite stellar fundamentals, it looks like Johnson & Johnson has a PE ratio in the 22.94 range right now (possibly a bit lower). I backed into this number, since EPS is thrown off by one-time tax items. Certainly, the stock is priced for perfection, but it always seems to be! While I'm not buying this stock in 2018 (other than reinvesting dividends), I do want to buy more. I'm waiting for a correction, although I never expect a big one with this stock. Of course, there are a few risk factors with JNJ. I close out discussing those potential risks: * Patent expiration and the need to always innovate in their pharmaceutical division. * Overall pricing of their products (the US health care system is broken). Want to learn more about my dividend growth investing strategies? Here are a few popular videos on how I would hypnotically invest different sums of money. Getting started with $1,000: https://www.youtube.com/watch?v=Iijz-5vGSh0 Getting started with $5,000 in dividend stocks: https://www.youtube.com/watch?v=5Bp0TzQKRr0 Getting started investing with $10,000: https://www.youtube.com/watch?v=4i_3KAY1ZMo Going big with $25,000 in dividend stocks: https://www.youtube.com/watch?v=CGrf5He8ieU Investing $50,000 in income-producing securities: https://www.youtube.com/watch?v=ishEcrSTK-c Want to connect on Instagram? Please make sure to say hi! https://www.instagram.com/ianlopuch/ Disclosure: I am long Johnson & Johnson (JNJ). I own this stock in my portfolio. Disclaimer: I'm not a licensed investment advisor, and today's video is just for entertainment and fun. This video is NOT investment advice. Also, I'm not a tax advisor and today's video is NOT tax advice. Please talk to your licensed investment advisor before making any financial decisions. All content on my YouTube channel is (c) Copyright IJL Productions LLC.
Просмотров: 9830 ppcian
Career Spotlight: Feed Sales
 
22:30
Have you ever dreamed about traveling and seeing the world all while working? If so, a career in sales might be the right path for you. Learn more about agriculture jobs: https://goo.gl/2d84jC. Life on the road can be difficult when traveling for work, but it can also be extremely rewarding and eye opening. Tyler Cockerham, a feed sales (http://aggrad.com/5-reasons-you-should-really-consider-a-career-in-ag-sales/) representative for Cargill Feed Nutrition, knows first hand the benefits a career in sales has for someone who wishes to see the world. Earning the windshield time As a feed sales representative, Tyler travels through Virginia, West Virginia and Maryland on a weekly basis. He drives about 1,000 miles a week, working with wholesale dealers, member cooperatives, independent co-ops and dealers, and some producers. He works with each customer account to market feed and act as a resource to them with their end user. Tyler starts most of his days bright and early, as most of his accounts are a two, three or more hour drive away from his home. He tries to plan his week prior to jumping in his truck to avoid crossing his path. “I thoroughly enjoy the time on the road — for some people they don’t like alone time in the truck or eating dinner by themselves, but you get used to it,” Tyler said. One lesson Tyler had to quickly learn with his job is to never make any firm commitments because circumstances — like the weather or rescheduled meetings —can change so quickly. “That is probably the hardest part of sales,” Tyler said. “With today’s technology and phones, you’re really never off. You’re always working.” In order to have a healthy work, life balance on the road, Tyler had to set boundaries. “It’s defiantly a challenge,” he said. “It takes awhile to figure it out. When I first started, I all but burned myself out.” Developing the passion Tyler’s passion for the cattle industry developed in high school when he began working for a local producer near his Virginia hometown. His interest in the industry drove him to pursue an agriculture degree at Mississippi State University. While at Mississippi State, Tyler applied for an internship at a ranch in Wyoming. He was hired for the internship and spent three months in Wyoming working on the commercial cow-calf ranch. The internship really drove him to seek a career in the cattle industry. Immediately after Tyler graduated from Mississippi State, he began working for JBS Five Rivers at a commercial feed yard in Dalhart, Texas. After working for JBS Five Rivers for a couple of years, Tyler received a LinkedIn message from a recruiter for a position with Southern States Feed in Richmond, Virginia. “I wasn’t really looking for a change, but I always keep an open mind for an opportunity (http://aggrad.com/4-questions-to-determine-a-great-long-term-opportunity/) to better myself,” Tyler said. “I spoke with (the recruiter) and she actually didn’t even know where I was originally from, which is Virginia. The opportunity to come home was great option (while) also still work in the animal livestock industry.” In 2017, Southern States Feed sold their feed business, which consisted of seven feed mills, its staff and the branded feed, to Cargill Feed Nutrition. “I’m still selling the same products to the same people,” Tyler said. “We’re really excited about being able to leverage the resources that Cargill has to really help our producers.” Walking the walk One of the biggest fears for individuals looking to pursue a career in sales is not knowing enough about the industry. Tyler’s advice to overcome that fear is education. Educate yourself and conduct research on the industry you wish to enter. Tyler educated himself by gaining “real life experience” he could draw from when talking to his customers. “I think having some “real life experience” helps because you can leverage that when you’re in conversations with dealers or stores,” he said. “When I was at Mississippi State, I worked at the dairy. So when I call on a dairy farm, I can draw off of that experience. (With cow-calf operations), I can draw from that experience in Wyoming. In West Virginia, we work with a lot of background and feed cattle. Just being able to say the word JBS kind of gets people’s attention. It gives you a little more credibility.” To reach out to Tyler, send him an email at tyler_cockerham@cargill.com. Subscribe to the AgGrad YouTube Channel to learn more about career opportunities in agriculture, and follow us online: Website: www.AgGrad.com Snapchat: @AgGrad http://aggrad.com/snapchat/ Twitter: @AgGradNation https://twitter.com/aggradnation Facebook Page: https://www.facebook.com/AgGradNation Facebook Group: https://www.facebook.com/groups/aggrad Instagram: https://www.instagram.com/aggrad/
Просмотров: 122 AgGrad
Traceability System
 
05:58
Web: www.infinityautomations.com Email: sales@infinityautomations.com What is Traceability? Traceability System can be defined as “the ability of the system to trace the history, application or location of an entity by means of recorded identifications.” For discrete manufacturers, the traceability system can track and trace each component that comprises your product – from suppliers and manufacturers through assembly and final delivery to customers. Basic of Traceability • Use of technologies such as direct part marking for discrete manufacturers, where parts and components receive a permanent mark either as they enter assembly or by suppliers. • 1D and 2D bar codes • Engraved marking system • To help close some of the information gaps that exist in disparate supply chains, track warranty data and meet customer safety and demand requirements. • Protect Your Reputation • Recalls are Costly… Benefits: • Achieve REAL-TIME • Real-time transparency • Increase customer satisfaction and safety • Meet government and compliance mandates • Improve data accuracy • Increase operational productivity • Protect your brand and bottom line • Reduce warranty claim costs • Focus on generating revenue Features:- • Identification of defects and prevention of outflow. • Data accumulation and applications. • In case of a problem with a machine in the field, once the product serial number is identified, the traceability system allows us to trace any quality-related information recorded at the manufacturing site. • The tracked information of our machines in the field is analyzed and used to prevent potential problems from occurring in the machines, and also to manufacture products with better quality at manufacturing sites. • Compatibility with various control system environments such as Siemens, Allen Bradley, Mitsubishi Etc. • In case of a machine malfunction in the field, once we identify the product's serial number, our traceability system allows us to trace, for example, the serial numbers of the installed parts, the factory inspection results, and any adjustments made prior to shipment. As a result, we can rapidly diagnose the cause of the malfunction and also list the machines that may experience problems, so that we can take some preventive measures. • Communications • Graphical Track and Trace • Part Status Storage • Reporting • Regulatory Compliance • Server Monitors and Diagnostics • Quality Control • Simple & Easy Turnkey Solution
Просмотров: 24 INFINITY AUTOMATION SYSTEMS PVT LTD
Can I have your brain? The quest for truth on concussions and CTE | Chris Nowinski
 
11:21
Something strange and deadly is happening inside the brains of top athletes -- a degenerative condition, possibly linked to concussions, that causes dementia, psychosis and far-too-early death. It's called chronic traumatic encephalopathy, or CTE, and it's the medical mystery that Chris Nowinski wants to solve by analyzing brains after death. It's also why, when Nowinski meets a pro athlete, his first question is: "Can I have your brain?" Hear more from this ground-breaking effort to protect athletes' brains -- and yours, too. Check out more TED Talks: http://www.ted.com The TED Talks channel features the best talks and performances from the TED Conference, where the world's leading thinkers and doers give the talk of their lives in 18 minutes (or less). Look for talks on Technology, Entertainment and Design -- plus science, business, global issues, the arts and more. Follow TED on Twitter: http://www.twitter.com/TEDTalks Like TED on Facebook: https://www.facebook.com/TED Subscribe to our channel: https://www.youtube.com/TED
Просмотров: 42145 TED
How to Calculate Mean Kinetic Temperature in Excel Sheet?
 
01:21
Here's how you can calculate Mean Kinetic Temperature in Excel Sheet? First Download the Excel sheet: https://store.vackerglobal.com/mean-kinetic-temperature-mkt-excel-sheet The MKT excel sheet will give you the mean kinetic value, maximum and minimum values and the average and can be used for temperature sensitive products. The Mean Kinetic Calculation is widely used in pharmaceutical industries. You can calculate in Fahrenheit as well. This Video explains all the information regarding Kinetic Theory and temperature, kinetic interpretation of temperature, kinetic energy, mean temperature, how to calculate mean kinetic temperature, mkt calculation, how to calculate mkt in excel, what is mkt, mkt calculation for pharma industry, excel mkt calculation. *** Transcript This video explains how to calculate Mean Kinetic Temperature in Microsoft excel. Upon opening the Excel file, please Enable Macros. There are two sheets, one for Degree Centigrade and another one for Fahrenheit. You have to simply insert the data into these rows. You can add or delete any number of rows or columns. Now copy the data from the data logger into these columns. I have a sample data stored separately. Insert as many rows as you want. Copy the data into these columns. Delete any empty rows. Now you can see the Mean Kinetic Temperature value, Maximum and Minimum values and the average. You can do a similar method for data in Fahrenheit as well. The formula used in =M K T ( ). Please go to our stores to download this MKT calculation tool. Also, contact us for Temperature mapping study, data loggers, construction of cold rooms, dehumidification solutions etc. for Cold Chain applications. *** Contact details: Vacker LLC 306, RKM Building, Ittihad Road, Hor Al Anz Deira, Dubai Tel: +971 42 66 11 44 Email : sales.uae@vackerglobal.com Group websites: http://www.sensorsuae.com/ https://www.vackergroup.ae/ https://www.temperaturemonitoringuae.com
Просмотров: 932 Vacker Global
Federal Indictment: Drug Company Officials Bribed Doctors To Prescribe Opioid | NBC Nightly News
 
02:04
Drug maker Insys bribed five Manhattan doctors with perks and payments of more than $800,000 combined to prescribe more of a drug that contains fentanyl, a federal indictment charged. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, Meet The Press, and original digital videos. Subscribe to our channel for news stories, technology, politics, health, entertainment, science, business, and exclusive NBC investigations. Connect with NBC News Online! Visit NBCNews.Com: http://nbcnews.to/ReadNBC Find NBC News on Facebook: http://nbcnews.to/LikeNBC Follow NBC News on Twitter: http://nbcnews.to/FollowNBC Follow NBC News on Google+: http://nbcnews.to/PlusNBC Follow NBC News on Instagram: http://nbcnews.to/InstaNBC Follow NBC News on Pinterest: http://nbcnews.to/PinNBC Federal Indictment: Drug Company Officials Bribed Doctors To Prescribe Opioid | NBC Nightly News
Просмотров: 1085 NBC News
Handheld Pill Press/ Mini Tablet Press Tutorials--How to Make Pill on Handheld Tablet Presser
 
03:51
http://www.kosbest.com/ Email:sales@kosbest.com Stainless Steel Handheld Pill Press from KOSBEST is a cost-effective to make pharmaceutical grade tablets in a wide range of shapes and sizes from 3mm to 20mm. Whether you are a personal user who wants to formulate your own food supplements or herbal remedies, or a commercial organisation that needs to make small numbers of tablets for research and development, this innovative new mini handheld tablet press has just met your demands. To make tablet on Handheld Pill Press, firstly, you should prepare the molds and tools: punches and dies, tweezer, allen key, spoon, hammer. And then after adjusting the position of punch and the filling depth through adjusting a screw set downside the presser, user could make pills following the 8 steps: Step 1: Put the upper punch in the pill press; Step 2: Put the middle die on; Step 3: Feed the power into the die and scrape off the residues; Step 4: Put the lower punch on; Step 5: Strike the punch with a hammer; Step 6: Remove the hammer, and horizontally transfer the punch and die together to annother zone; Step 7: Press down the punch, so as to eject the pill out, then remove the punches and dies; Step 8: Take out the pill by a tweezer After that, the pill is finished. Following the video, Pill A215 and 512 Pill made on KOS Handheld Pill Press are demonstrated, and you can get a clear understanding of the whole process of the tablet press. For more tablet pressing machine and punches and dies, please visit our product website: http://www.kosbest.com
Просмотров: 1323 KOSBEST
John Schoonbee: Panel discussion on "What evidence can we trust?"
 
01:02:28
John Schoonbee, Global Chief Medical Officer, Swiss Re, moderated the panel discussion on "What evidence can we trust?" at the Swiss Re Institute's "Food for thought: The science and politics of nutrition" conference on 14 - 15 June 2018 in Rüschlikon. Find out more about the event: http://institute.swissre.com/events/food_for_thought_bmj.html Panellists of this discussion: Zoë Harcombe, Author and Researcher Aseem Malhotra, Consultant Cardiologist and Member, Academy Of Medical Royal Colleges Obesity Steering Group Rita Redberg, Professor of Medicine, University of California, and Chief Editor, JAMA Internal Medicine Gary Taubes, Science and Health Journalist, Co-Founder and President of the Non-Profit Nutrition Science Initiative Walter Willett, Professor of Epidemiology and Nutrition, Harvard T.H. Chan School of Public Health; Professor of Medicine, Harvard Medical School
Просмотров: 1780 Swiss Re
Empire Files;  Death & Biostitutes;  The US Opioid Crisis
 
21:57
https://www.telesurtv.net/english/news/Empire-Files-Abby-Martin-Talks-US-Opioid-Crisis-With-Mike-Papantonio-20171130-0017.html In 2016, 64,000 people died from drug overdoses in the United States, with roughly 80 percent of those deaths connected to opioids, according to a new report. The level of addiction has increased by almost 500 percent over the last six years. RELATED: Critics Say Trump's Opioid Epidemic Plan Is 'Counteractive' However, the question hanging on every concerned parent’s lips is where so many people could possible access that amount of drugs. Attorney Mike Papantonio believes the answer is as close as neighborhood clinics. In an exclusive interview with Abby Martin, the law professional — who made his name with triumphant lawsuits against big tobacco, chemical corporations and more — said he plans to take the United States' opioid crisis by the horns. Statistics show that 95 percent of suboxone sold in the world is sold in the United States and that one week of opioid use is enough to kick-start a severe addiction. With support from major distributors, pharmaceutical producers like Purdue Pharma were able to get their products into every hospital in the nation. Cleverly-crafted informative pamphlets describing addiction-free painkillers as well as pressure from federal health departments for critics was all it took to introduce dangerous substances such as Oxycodone into a patient’s daily prescription. Papantonio said that companies like Purdue are not the only corporations at fault. Major distributors like McKesson, Cardinal Health and AmerisourceBergen kept the lie alive when training new doctors. These distributors specifically targeted the nation’s poorer areas, former industrial towns with high unemployment, like Detroit, and poverty-stricken mining sectors in West Virginia. “They had done their homework and they figured out if somebody’s out of a job or somebody’s moved from the middle class to barely staying alive, that there’s despair that follows," he said, adding that investigations show that these sections are booming with distributors. The lawyer pointed to the growing number of sales, saying that in a town with a population of three million, distributors might sell as many as 700 million opioids. The addiction rate in these lower-class sectors has rocketed, transforming what began as a US$500 billion company into a US$500 billion industry almost overnight. “What they did, is they made this addiction issue part of their business plan,” Papantonio said. "They internalized what was happening out there on the street to become part of their business." He added that opioids then become a gateway drug for heroin. The pattern between former distribution hubs and spikes in heroin overdose admittances provide ample proof. “People ask me all the time, ‘Well, is this bigger than tobacco?’ This is much bigger than tobacco. This targeted our children,” Papantonio said. Although medical professionals are now taking action, the damage has already been done and only taking down these major corporations will make a difference for future generations, he added. RELATED: Cherokee Nation Sues Drug Firms over Opioid Crisis “My goal and what I’m doing nationally, I want to get all these cities and states, I want to get their money back for them, but I really want to make sure that some of them (corporate leaders) go to prison.” Papantonio explained that if they’re caught, the only regulation in place able to punish a corporation is the 1970s-era Substance Act, which only requires companies pay a fine for misdemeanors. Frequently, however, these same corporations will turn around and write off the fine as a business expense, leaving the federal government and taxpayers to “flip the bill.” The attorney said he’s hoping to take these companies to court with separate cases for each entity, adding that unlike other lawyers before him, he has no intention of settling. In the past, attorney generals have walked away from their cases after a US$50-$100 million settlement, a menial sum to a major corporation. “Yeah, they wear Armani suits and they have Rolex watches and they drive Bentley’s around. They come from great schools and live in Hamptons, and so we don’t look at them like criminals, so we don’t put them in prison.”
Просмотров: 3532 aplanetruth.info
Inkjet Test Printing- BAGS, Pails, Labels, Handheld Inkjet REINER...
 
08:01
https://shop.neumannmarking.com/collections/reiner Reiner JetStamp 790MP is very unique and useful Handheld Inkjet Printer. Used for marking Lot numbers, Batch numbers, Expiry Dates, Best Before dates on Food and Beverage Packaging, Pharmaceutical Packaging, Health and Beauty Packaging etc. Leave us a comment if you'd like Test Prints on your products. https://shop.neumannmarking.com/collections/reiner
5th International Fleet Meeting Geneva 2018
 
02:45
Very successful International Fleet Meeting 2018 at the Geneva Motor Show For the fifth time, the International Fleet Meeting took place as part of the Geneva Motor Show. Participants were hosted by top-class speakers including Michael Müller, Director Head of Mobility & Facilities, Daiichi Sankyo Europe GmbH as well as Marc A. Odinius, Managing Director Dataforce GmbH. An exciting panel discussion and opportunities for informal networking rounded off the event. On 7th March, 2018, it was time again: the second media day of the International Motor Show was dedicated to the fleet sector. 250 fleet managers and representatives of the automotive, leasing and service industries from all over the world met at the International Fleet Meeting. The two co-organizers, fleetcompetenceeurope GmbH and the Swiss fleet magazine aboutFLEET, were able to offer the international fleet industry in Geneva a unique, English-speaking platform. In his presentation, Michael Müller, Senior Director Head of Mobility & Facilities, Daiichi Sankyo Europe GmbH, introduced the new mobility concept of Daiichi Sankyo. With this concept, the pharmaceutical company is breaking new ground: for example, employees receive a so-called mobility budget. This allows the combination of different forms of mobility, which, according to Müller, benefits both the companies and the environment, as well as the employees. The employees are free to choose the mobility budget or, alternatively, to continue driving a company car. Meanwhile, about 25 percent of Daiichi Sankyo employees are not using company vehicles. Then, Marc A. Odinius, Managing Director of Dataforce GmbH, gave an exciting insight into the tendencies of the European fleet market. According to the latest statistics of Dataforce, Sport Utility Vehicles (SUV) are in vogue with companies as well. Alternative-powered company vehicles are also on the upswing, while diesel will continue to lose market share in the future. However, this does not deceive the fact that in addition to the propulsion systems, mobility behaviour (e.g. utilisation of vehicles) is facing fundamental changes in order to ensure mobility in future, according to Odinius. The subsequent panel discussion moderated by Thilo von Ulmenstein, Managing Partner of fleetcompetence europe GmbH, was joined by Hervé Girardot, Head of Arval Consulting & Corporate Vehicle Observatory, as well as Stuart Donnelly, Senior Director – Group International Sales Northern Europe & USA at Sixt. As per a representative survey of 3000 fleet managers, according to Girardot, the majority of respondents said they were open to alternative fleet vehicles. However, only two percent of fleet manager would give up their own company vehicle. Müller countered that this was in consequence of a lack of alternatives. If mobility options were going to turn out more attractive in the future, more employees would give up a vehicle voluntarily. On this, Donnelly pointed out that not using a car is not least dependent on the topography and the culture of each particular country. The panel discussion was rounded up by questions of the audience before the fifth International Fleet Meeting came to a successful end with food, drinks, and a lot of networking. The International Fleet Meeting 2018 was supported by the gold sponsors Arval and Alphabet as well as the silver sponsors Chevin, FleetLogistics, fleet.tech, Hertz, Sixt Leasing, Socar, Traxall, and Volkswagen Financial Services AG. Additionally, the IFM was able to count on the media partnership with Aegfa, Autoflotte, China Automotive Review, FleetEurope, Fleet Magazine, Fleet Management Weekly, Fleet&Mobility, Flotila, Flottes Automobiles, FLOTTE&Wirtschaft, International Fleet World, Menadzer Floty, and Mission Fleet. For information and pictures of the event visit www.internationalfleetmeeting.com.
Просмотров: 14 fleetcompetence europe GmbH
Digital Pharma Europe exl AS
 
01:59
Digital Pharma Europe (exl) AS At Radisson Blu Edwardian, Heathrow For more information: https://www.eventbrite.com/e/digital-pharma-europe-exl-as-tickets-39219077316?aff=RMV DESCRIPTION ============ In an effort to provide our most diverse pharmaceutical and medical device executive mix to date, this year’s venue provides a centralized platform that is close to numerous UK pharma headquarters as well as Heathrow Airport. This will also allow for easy access to UK pharmaceuticals and medical device organizations and facilitate expedited travel time for European and US counterparts. By bringing together over 200 life-science industry marketers, you will be able to employ a roadmap for a fully digitalized enterprise — no what your core business offering is There are some exciting potential solutions on the horizon, but still many questions being asked: How will digital disruption transform the pharma business model? How can pharma leverage digital and navigate digital trends and technologies to maximise positive outcomes for patients? How can pharma generate value from digital medicine solutions? As pharma companies shift from implementing traditional products to connected solutions, companies are challenged to define and realise value from this new business model (e.g., revenue stream) that intelligent digital medicine solutions require. How can pharma engage with disruptive technologies? How can we demonstrate the value of digital for pharma products? Pharma companies are increasingly exploring the role that digital can play in demonstrating value through data, analytics, and real-world evidence. How will pharma adapt to successfully engage HCPs? As HCPs evolve in their engagement with patients and how they manage their practice, pharma companies will have to transform their HCP-engagement approach. We will explore these questions and more. Join the conversation and contribute to the advancement of digital health to improve patient outcomes and customer centricity! Reserve your seat for the 10th anniversary of the Digital Pharma Europe conference. We look forward to celebrating this milestone with you in London this May! For more information: https://www.eventbrite.com/e/digital-pharma-europe-exl-as-tickets-39219077316?aff=RMV “What Exactly Will I Learn?” ============================ Drive Optimized Marketing And Digital Operations, Launch Readiness And Marketing Capability By: Establishing product launch excellence and launch models for multiple therapeutic categories Measuring success in digital ROI and evaluating digital analytics Global digital transformation HCP user experience — user research — visualization and journey tools Enhancing commercial planning quality by increasing alignment among Marketing, Medical, Finance & Sales functions Improve the overall quality of strategic brand plans across BUs by developing a more patient-centric approach and delivering innovation in patient centricity Grow e-SOV for your brands by: ============================== Leveraging HCP portals across the globe — how to lead from strategy into deployment across high numbers of markets Digital engagement and programming for HCPs, 360 views, etc. Developing market-leading content strategy and targeting around e-mail magazines and Veeva approved e-mails Execute successful webcasts Improve handling of marketing material and increased i-detailing usage to increase rep call quality and sales The evolving tools and tactics of digital to improve patient quality of life and outcomes, e.g. AI and remote diagnostics Omnichannel optimization — identifying the optimal channel mix, timing of digital and sales visit that lead to drug adoption Optimized content production through the set up of a new asset management process Please contact the event manager Marilyn below for the following: - Discounts for registering 5 or more participants. - If your company requires a price quotation. Event Manager Contact: marilyn.b.turner(at)nyeventslist.com You can also contact us if you require a visa invitation letter, after ticket purchase. We can also provide a certificate of completion for this event if required. ---------------------------------- For more information: https://www.eventbrite.com/e/digital-pharma-europe-exl-as-tickets-39219077316?aff=RMV Eventbrite: https://www.eventbrite.com/o/event-promotions-by-new-york-events-list-11118815675 Twitter: https://twitter.com/nyeventslist Facebook: https://www.facebook.com/NewYorkEventsList New York Events List: http://nyeventslist.com/
Просмотров: 5 New York Events List
FBP 151: Crushing It with Messenger Chat Bot Marketing Expert Niel Reichl
 
01:22:04
A combination of relentless drive and plenty of hard work turned unfortunate events into opportunities for our FBP 151 guest. This guy with an easy demeanor and bright outlook has also proved himself to be resilient and a fast learner. In 3 years, Neil Reichl has turned from a pharmaceutical sales rep to a ChatBot marketing expert. All the long drives that he made while listening to podcasts when he was still a sales rep turned out to be the training ground for his digital marketing and freelancing career. WHY CHATBOT MARKETING? An early adopter of ChatBot marketing, Neil recognized the need for a more effective way of getting leads and engaging with old both old and potential customers. With an even tougher competition now as all types of media are clamoring for a person’s already short attention span, how does a business get their voice heard loud and clear? With email marketing effectivity slowly dropping (25% open rate, 3% CTR), Neil saw how more people, regardless of age or status, are now more likely to use Facebook Messenger as their main means of communication. It is not surprising that statistics for Facebook Messenger Marketing campaigns show an 89% open rate with a 50-60% CTR. For instance, the reach can be greater too as people who may not follow or “like” your page can still send you a message and contact you on Facebook. Are you as interested as I am now? I too believe that ChatBot marketing is the next big thing so I signed up for Neil’s ChatBot marketing premium course to learn more about it. If you want to see a ChatBot in action, watch the FBP 151 video to see a demo of how a ChatBot can bring in more leads and convert fans into paying customers. KEY HIGHLIGHTS FBP 151 comes with loads of useful tips from Neil. Also, you will get the chance to see us in our formal wear! QUOTES Neil on how to effectively use ChatBots: “Courtesy should always be your first step” Marv on taking new challenges from clients: “Say yes and learn it.” Neil on avoiding analysis paralysis: “Take action!” LINKS - See a ChatBot in action here: http://bit.ly/chatbotMarv - ManyChat.com - Do you want to get more tips for fellow freelancers? Join us on Facebook and connect with hundreds of Filipino freelancers! https://www.freelanceblenders.com
Просмотров: 45 FreelanceBlend
Abandoned Pilgrim State Psychiatric Center
 
01:17:43
Apologize had to remove the song from the beginning so no sound for 2 min. We explore the abandoned pilgrim psychiatric center. This center in 1954 was home to over 13,000 patients. Join us as we explore the remnants of this old facility. After World War II, Pilgrim State Hospital experienced an increase in patient population that made it the world's largest hospital, with 13,875 patients and over 4,000 employees. In the 1950s more aggressive treatments, such as lobotomy and electro-convulsive therapy (ECT) were implemented. The best known controversy about this surrounded the case of Beulah Jones, a patient there between 1952 and 1972 who received both such treatments and was left seriously impaired. However, Pilgrim State Hospital and the other state hospitals began to decline shortly afterwards with the advent of pharmaceutical alternatives to institutionalization. Dr. Henry Brill served as the director of Pilgrim from 1958 to 1974 and presided over both the introduction of the new anti-psychotic medications and the large numbers of discharges related to good response to these medications. Be sure to check out all our channels and videos below: Urban Ghost Urban Exploration (UGUE): https://www.youtube.com/channel/UCSzuL8cKMva9fQxjENTb9tw The G-Team Paranormal: https://www.youtube.com/channel/UCRERFUVI8WDxoN3JVzmp6UQ Be sure to also check out our social media social media: Instagram: holywalk_s t Twitter kyle and Ethan: @IN2-Wonderland_E Twitter Todd holywalker's: @holywalkers_s Twitter Ethan holywalker's: @holywalkers_E Facebook: Holywalker's Music:BLACKOUT / NO CEILINGS (Prod. Wocki Beats) by EULOGY THE SEWER GOD https://soundcloud.com/eulogy2013/blackout-no-ceilings-prod-wocki-beats-1 on #SoundCloud
Просмотров: 1186 HOLYWALKER' S
Jeff Bezos at MIT  Amazon - Earth's Most Customer-Centric Company
 
01:21:55
Please Subscribe!http://www.youtube.com/c/MITVideoProductions?sub_confirmation=1 In this lively presentation Jeff Bezos, Founder and CEO of Amazon.com discusses many of the technological advances that have enabled Amazon.com to be the "earth's most customer centric company". Bezos talks about Amazon's first 30 days of operation, shows the very first home page and explains how the existence of a little known book warehouse in Roseburg Oregon led to the decision to locate Amazon in Seattle. Since 1997, Amazon has spent $800 million on technology, more than it has spent on either warehousing or marketing. A self-proclaimed "EECS-geek", Bezos tells of technological advances that have not only enabled customers to find products, (and now at 28 million items), enabled products to find customers. Hear how Amazon developed "real time personalization", how the company performs "active experiments" and learn more about salad spinners than you could ever imagine. Also appearing is MIT alum Robert Frederick, Manager of Amazon Net Services. Frederick explains how these services enable other retail services to interact with Amazon. Hear how the company that "runs on computer science" plans for more technological advances in the future. http://www.youtube.com/c/MITVideoProductions?sub_confirmation=1
Просмотров: 3792 MIT Video Productions
Fresh Email Database 2018
 
01:14
So you're a businessman and you want to run a successful business but getting in touch with the right customers it's not as easy as you thought it was as the conversion rates of your sales team but it rock bottom because they arn't contacting the right people you have two options you can either spend ages and creating a list of valuable contacts who would be interested in your service or you can logon to www.freshemaildatabase.com and simply buy the email database of you the target customers from us it's a no-brainer whether you own a pharmaceutical company or a jewelry retail business we can get you the golden lists that can increase your conversion rates , our databases are always up to date with the latest email address his phone numbers contact info and many other forms of contact info there or even categorically organized for your convenience just log onto logon to www.freshemaildatabase.com instantly purchase and download a male databases that can optimize your marketing strategy
Просмотров: 18 Email Marketing
5 Stocks to WATCH in JUNE 2018 📈| Top 5 Stocks to WATCH INVESTor TRADE| JUNE Stocks I'm Watching
 
10:29
5 Stocks to WATCH in JUNE 2018 📈| Top 5 Stocks to WATCH INVESTor TRADE| JUNE Stocks I'm Watching. I will provide the information about the Top 5 to WATCH stocks in JUNE 2018. You can do one of the following choices or mix of all optons: You can use the following top 5 stocks to watch in JUNE, you can use the top 5 stocks to do more research in JUNE, or you can use the top 5 stocks to invest in JUNE or you can use the top 5 stocks to trade in JUNE, or you can use the top 5 stocks to buy in JUNE. Keep in mind, these are just some stocks to trade or stocks to watch or to stocks to invest in, it just depends on your investing style. These are the best 5 stocks in 2018 that have gone up a significant good amount. You can use the Top 5 stocks to watch. Even if you don't watch the stocks, you can add them in your list in the stocks to watch JUNE 2018. In addition, I see the trend to continue going up. here is the list of best stocks to invest in 2018. Remember, we are in a bull market right now, this will present an opportunity to have the stocks to buy now. Keep in mind some of the stocks can be used as stocks to trade, it just depends on your stock market style. This is just a small list of the best stocks in JUNE. Also, there are a lot of earnings that are happening this month. After watching the video, you might decide that these are the top stocks in 2018. From the look of it and how the stocks have managed to improve during these few months in 2018, it looks like it. Keep watching the Financial information channel if you want to get more videos about the top stocks to buy or stocks to invest. In additions, you can add some of these stocks to invest in 2018 and should do good in terms of return. You can have these stocks also as some of the stocks to invest in 2018. I will present the 5 Stocks for JUNE 2018: I would consider for myself the best stocks to buy and the best stocks to watch in 2018. Remember, if you prefer not to trade or invest, you can use this video as the stocks to watch in JUNE 2018 and add them into your list. These are just some of the stock picks JUNE 2018. In addition, remember these are my stock picks for JUNE. Also, it could be considered the best stocks to buy now depending on the time and date when you watch the video. Also, some of these stocks i'm buying now are included in this video. Lastly, the video contained some stocks for beginners which help you start investing the right way. SUBSCRIBE: http://bit.ly/FinancialinfoYT Robinhood APP FREE Stock Trading►http://bit.ly/FinancialRobinhood These are the TOP 5 books for investors and the links where you can find them on Amazon website: • The Little Book of Common Sense Investing - http://amzn.to/2xS4T4K • The Intelligent Investor - http://amzn.to/2xcEiCu • One Up on Wall Street - http://amzn.to/2xQpmqL • How to Make Money in Stocks - http://amzn.to/2g8Lm8J • Rich Dad Poor Dad - http://amzn.to/2xeGKZi Financial Information on Social Media: FACEBOOK ➡️ https://www.facebook.com/fin.information/ INSTAGRAM ➡️ https://www.instagram.com/fin_information/?hl=en TWITTER ➡️ https://twitter.com/Fin_information WEBSITE ➡️ https://fininformation.com/ ---------Equipment Used To Shoot This Video ------- Camera ➡️ http://amzn.to/2pjTJQO Lens ➡️ http://amzn.to/2nZevVt Tripod ➡️ http://amzn.to/2pjOgtt Tripod Head ➡️ http://amzn.to/2nZuovp Microphone ➡️ http://amzn.to/2ooQQRB Lighting ➡️ http://amzn.to/2nwHRhX DISCLAIMER: This video and description contains affiliate links, which means that if you click on one of the product links, I’ll receive a small commission. This helps support the channel and allows us to continue to make videos like this. Thank you for the support! DISCLAIMER: I do not provide personal investment advice and I am not a qualified licensed investment advisor. All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies. I will not and cannot be held liable for any actions you take as a result of anything you read and/or view here.
Просмотров: 3507 Financial Information
California's drug transparency law yields early surprises
 
08:23
California’s first-in-the-nation drug pricing transparency law is beginning to kick in — and to spur copycats, with Oregon’s governor last week signing a law that requires drug companies to disclose cost components they have long considered proprietary. Whether they’ll actually reduce prices is a crapshoot. California has already pried loose new numbers that may seem deja vu: Valeant, a magnet for criticism over past price boosts, is about to raise the price of a generic glaucoma medication by 63 percent, and Teva Pharmaceuticals, the world’s biggest generic drugmaker, plans a 49 percent price bump May 1 for an inhaled solution to prevent asthma attacks, according to documents obtained by POLITICO. The notifications are early results of the California law that in January began requiring drug companies to give major purchasers 60 days’ notice of significant increases. While it doesn’t directly affect prices, proponents hope that advance warnings — and mandating that manufacturers justify the increases — will generate enough public pressure to hold down prices. The wholesale price for the medications that trigger the notifications will be available to the public next year. “We’re going to be able to look at industry pricing activity in a way the public and the rest of us haven’t been able to track before,” said Jane Horvath, who heads the National Academy for State Health Policy’s Center for State Rx Drug Pricing. Other experts remain dubious. “We’ve seen massive, massive price increases, and shame has not trumped profit. After a while, people get numb to it,” said Adams Dudley, a pulmonologist and director of the University of California, San Francisco’s Center for Healthcare Value. Indeed, both Valeant and Teva have weathered these controversies before — just not in advance of an actual price hike. Valeant in 2015 raised the price of Syprine, which treats a rare disorder, to $21,000 — more than 30 times what it had been five years earlier. Teva recently introduced a “lower-cost” generic for $18,000 for a bottle of 100 pills, 28 times the 2010 brand price. Valeant then came back with an “authorized” generic for $19,000. With stories like these playing out across the country, California sees another area where it can play national leader. Gov. Jerry Brown explicitly described the transparency measure — supported by a broad coalition of insurers, employers and advocates arrayed against vehement drug industry opposition — as a model for other states when he signed it in October. Several states, including Massachusetts and Nebraska, have similar legislation pending. More than 150 bills have been introduced nationwide to address at least some aspect of prescription drug costs, according to the National Academy for State Health Policy. The industry sees California as a leader, too, and sued to stop the law. In a statement when the complaint was filed in December, the drug lobby PhRMA contended that the law illegally attempts to "dictate national health care policy" and thwart competition but declined further comment. The next set of legal filings is due Monday. Pharma trade groups also filed suit over laws in Maryland and Nevada that attempt to tackle drug prices in other ways. Oregon could be next. The sponsors of Oregon’s new transparency law say they closely watched California’s progress as they developed their own measure and felt emboldened when Sacramento passed it. But a provision in the Oregon bill that would have required advance notification of significant price increases, like California does, was negotiated out before passage. “The pharmaceutical industry doesn’t compromise on anything. They just say ‘no,’” said the bill’s primary author, state Rep. Rob Nosse. But Nosse, a Portland Democrat, is pleased: “Our version of transparency, I would argue, is a little more aggressive than what [California] did,” he said. Oregon will require drug companies to reveal research and development costs, profits, total sales, marketing outlays and other information relevant to price increases over 10 percent a year beginning in July 2019. California’s law has several key parts that will take effect this year and next. The law’s next phase begins Oct. 1, when health plans will have to report to the state the top 25 medications prescribed to their participants, which drugs cost payers the most and which experienced the largest aggregate year-over-year price increases. Starting on Jan. 1, 2019, the state is required
Просмотров: 1 NEWS HEADLINES CN1
Dabur India Ltd Investors Conference Call Qtr4 FY18
 
01:11:51
Dabur India ltd. Management answering questions from Investors and Financial Analysts after declaring their quarterly results. Dabur India concall, Full Earnings Call Audio. Tap into the wisdom of the large investing network and empower yourself to make smarter and well informed investment decisions. Visit http://www.stockadda.com Share QTR3 FY18 Concalls playlist link with your friends: https://www.youtube.com/stockadda Qtr4 FY18 Concall Playlist: https://www.youtube.com/playlist?list=PL5lVE_EuOGIglKr7114ObzpdMAkAkJpn6 Qtr3 FY18 Concall Playlist: https://www.youtube.com/playlist?list=PL5lVE_EuOGIjgc_coaCn7GIQpjTfALF5D Follow us on Twitter: https://twitter.com/stockadda Like our Facebook Page: https://www.facebook.com/Stockadda.india #stockmarket #investing #concall #EarningCalls #investors #QuarterlyResults #interview #DaburIndia
Просмотров: 57 Stockadda
Baum Century Series Print/Gather/Fold/Barcode Verification/Document Inserting System
 
03:06
The New Baumfolder Print, Gather, Fold, Inserting System. As the Konica Minolta 1250P prints the invoice, packing list, marketing material, document the Baumfolder system has a divert system installed that allows testing or jam prevention. This prevents most kinds of jams in the system; the flap will automatically come up and divert the sheets into an automatic tray that you can remove by hand. Normally the sheets will then go into an ionizer system that Baumfolder has installed. What does an ionizer do? It removes all that static electricity the copier has put into the sheets by heating the paper. Because, static if not removed can lead to jamming, double sheets curls when you are trying to insert into a box, static is your worse enemy. As the sheets come into the gathering system the round belts, gather the sheets on top of each other until the specified numbers of sheets are gathered. The gate will come down and release those sheets into the fold system. The Baumfolder folding system has been around for 100 years, doing various folds for all types of Graphic Industries. Then we go into the Baumfolder staging units. It is a belt over belt system. What this unique system does, as the sets of folded invoices, packing list, personalized documents are folded they go into a staging system that organizes the documents until the correct box has arrived down the conveyor system. Barcode verification was completed on the document and box verifying that both are the same. Then the document is inserted precisely into the box. As that box is inserted the next box comes down the conveyor line, and our system will automatically index those invoices in our staging system so we can insert as soon as the box is ready. Each unit comes with a personalized console system. This console will show verification codes, speed and error codes on the system. The touch screen can be mounted so the operator can easily read and clear jams or errors and keep production running. For more information please contact us at sales@baumfolder.com or call 800-543-6107
Просмотров: 261 Baumfolder Corporation
John Ioannidis: The role of bias in nutritional research
 
41:56
John P.A. Ioannidis, C.F. Rehnborg Professor in Disease Prevention in the School of Medicine, and Professor, by Courtesy, of Statistics and Biomedical Data Science, Stanford University, presented "The role of bias in nutritional research" at the Swiss Re Institute's "Food for thought: The science and politics of nutrition" conference on 14 - 15 June 2018 in Rüschlikon. Find out more about the event: http://institute.swissre.com/events/food_for_thought_bmj.html
Просмотров: 1117 Swiss Re
Industrial output increased 4.5% y/y in Jan.
 
01:34
1월 산업생산 전년동월대비 4.5% 늘어 South Korea's industrial output recovered in the month of January. This comes on the back of improved production in the auto and semiconductor sectors..., the traditional key drivers of the nation's growth. Kim Ji-yeon give us a rundown of the encouraging digits. Industrial output of overall industries in Korea increased four-and-a-half percent in January compared to the same period last year. Statistics Korea says output jumped one-point-two-percent from the previous month,... the steepest rate of increase in ten months. It attributes the spike to increased production in the auto sector, which grew more than twelve percent on-month... thanks to releases of new models and a base effect stemming from sluggish auto exports to the U.S. and the Middle East. A rebound in the auto and semiconductor sectors helped boost output in the mining and manufacturing sectors... which grew one-percent from the previous month in January... the first on-month increase in three months. Retail sales also spiked one-point-seven percent from the previous month on increased output of automobiles and durable goods. A rebound in the auto sector also helped to boost facility investment which rose by more than six-percent from the previous month... the fastest rate of increase in ten months. Production in the services sector also jumped zero-point-eight-percent compared to the previous month,... mainly due to increased output in science and technology. However, output in the food and lodging sectors dropped one-point-three percent from the previous month... declining for the fourth straight month in January. Kim Ji-yeon, Arirang News. Arirang News Facebook: http://www.facebook.com/arirangtvnews ------------------------------------------------------------ [Subscribe Arirang Official YouTube] ARIRANG TV: http://www.youtube.com/arirang ARIRANG RADIO: http://www.youtube.com/Music180Arirang ARIRANG NEWS: http://www.youtube.com/arirangnews ARIRANG K-POP: http://www.youtube.com/arirangworld ARIRANG ISSUE: http://www.youtube.com/arirangtoday ARIRANG CULTURE: http://www.youtube.com/arirangkorean ------------------------------------------------------------ [Visit Arirang TV Official Pages] Facebook: http://www.facebook.com/arirangtv Twitter: http://twitter.com/arirangworld Instagram: http://instagram.com/arirangworld Homepage: http://www.arirang.com ------------------------------------------------------------ [Arirang K-Pop] YouTube: http://www.youtube.com/arirangworld Facebook: http://www.facebook.com/arirangkpop Google+: http://plus.google.com/+arirangworld
Просмотров: 55 ARIRANG NEWS
Customer Experience and Customer Service at Pinterest (CXOTalk # 290)
 
47:28
How does a company like Pinterest ensure that site viewers, brands, sponsors, and "pinners" have a great experience? Michael Krigsman, industry analyst and host of CXOTalk, speaks with Dutta Satadip, the Head of Global Customer Operations at Pinterest, about customer success. Read the complete transcript here: https://www.cxotalk.com/episode/customer-success-secrets-pinterest Dutta is responsible for building a scalable customer success organization that drives customer lifetime value through operations. Prior to Pinterest, he was the Director of Customer Success for the Americas region at Google. He comprehensively drove customer retention, accomplished sales targets, and scaled operations across a multi-billion dollar portfolio of over 150 products with teams in 15 different offices. He has more than 20 years of industry experience and has held various senior leadership roles in most key operating areas, including Pre-Sales, Business Operations, Product Strategy, Product Management, Product Marketing, Engineering as well as Consulting positions. He specializes in transforming organizations by identifying the right strategic levers to drive the business while minimizing risk. Dutta has operated extensively in both developed and emerging countries. Dutta frequently speaks at major conferences including TEDx on management topics such as Change Management, Customer Success, Operations, Leadership and Building diverse teams. He has served on the board of the National Hemophilia Foundation and Save One Life.
Просмотров: 5136 CXOTALK
California's drug transparency law yields early surprises
 
03:29
California’s first-in-the-nation drug pricing transparency law is beginning to kick in — and to spur copycats, with Oregon’s governor last week signing a law that requires drug companies to disclose cost components they have long considered proprietary. Whether they’ll actually reduce prices is a crapshoot. California has already pried loose new numbers that may seem deja vu: Valeant, a magnet for criticism over past price boosts, is about to raise the price of a generic glaucoma medication by 63 percent, and Teva Pharmaceuticals, the world’s biggest generic drugmaker, plans a 49 percent price bump May 1 for an inhaled solution to prevent asthma attacks, according to documents obtained by POLITICO. The notifications are early results of the California law that in January began requiring drug companies to give major purchasers 60 days’ notice of significant increases. While it doesn’t directly affect prices, proponents hope that advance warnings — and mandating that manufacturers justify the increases — will generate enough public pressure to hold down prices. The wholesale price for the medications that trigger the notifications will be available to the public next year. “We’re going to be able to look at industry pricing activity in a way the public and the rest of us haven’t been able to track before,” said Jane Horvath, who heads the National Academy for State Health Policy’s Center for State Rx Drug Pricing. Other experts remain dubious. “We’ve seen massive, massive price increases, and shame has not trumped profit. After a while, people get numb to it,” said Adams Dudley, a pulmonologist and director of the University of California, San Francisco’s Center for Healthcare Value. Indeed, both Valeant and Teva have weathered these controversies before — just not in advance of an actual price hike. Valeant in 2015 raised the price of Syprine, which treats a rare disorder, to $21,000 — more than 30 times what it had been five years earlier. Teva recently introduced a “lower-cost” generic for $18,000 for a bottle of 100 pills, 28 times the 2010 brand price. Valeant then came back with an “authorized” generic for $19,000. With stories like these playing out across the country, California sees another area where it can play national leader. Gov. Jerry Brown explicitly described the transparency measure — supported by a broad coalition of insurers, employers and advocates arrayed against vehement drug industry opposition — as a model for other states when he signed it in October. Several states, including Massachusetts and Nebraska, have similar legislation pending. More than 150 bills have been introduced nationwide to address at least some aspect of prescription drug costs, according to the National Academy for State Health Policy. The industry sees California as a leader, too, and sued to stop the law. In a statement when the complaint was filed in December, the drug lobby PhRMA contended that the law illegally attempts to "dictate national health care policy" and thwart competition but declined further comment. The next set of legal filings is due Monday. Pharma trade groups also filed suit over laws in Maryland and Nevada that attempt to tackle drug prices in other ways. Oregon could be next. The sponsors of Oregon’s new transparency law say they closely watched California’s progress as they developed their own measure and felt emboldened when Sacramento passed it. But a provision in the Oregon bill that would have required advance notification of significant price increases, like California does, was negotiated out before passage. “The pharmaceutical industry doesn’t compromise on anything. They just say ‘no,’” said the bill’s primary author, state Rep. Rob Nosse. But Nosse, a Portland Democrat, is pleased: “Our version of transparency, I would argue, is a little more aggressive than what [California] did,” he said. Oregon will require drug companies to reveal research and development costs, profits, total sales, marketing outlays and other information relevant to price increases over 10 percent a year beginning in July 2019. California’s law has several key parts that will take effect this year and next. The law’s next phase begins Oct. 1, when health plans will have to report to the state the top 25 medications prescribed to their participants, which drugs cost payers the most and which experienced the largest aggregate year-over-year price increases. Starting on Jan. 1, 2019, the state is required to launch a public database of those price increases. Advance notification of wholesale acquisition costs — basically drugmakers’ list prices for direct purchasers — was the first part to take effect. Most of the increases reported to major purchasers were under 10 percent, although the law requires notice only of jumps exceeding 16 percent over two years. Health care inflation overall has been running under 2 percent annually in recent years. The two largest increases in the documents made a
Просмотров: 9 NEWS HEADLINES CN1
Market to Market (February 9, 2018)
 
26:51
A bankruptcy placed directly at the feet of renewable fuel regulations. Urban consumers get fresh produce from a different kind of container. Market analysis with John Roach.
Просмотров: 645 Market to Market
2018 Gubernatorial Democratic Debate - (USC)
 
59:04
06/04/2018 - Broadcast live from Drayton Hall at the University of South Carolina. The democratic candidates for Governor are: Phil Noble, James Smith, and Marguerite Willis. Learn More: https://www.scetv.org/television/programs/state-house-today
Просмотров: 1535 SouthCarolinaETV
“Behave More Sexually:” How Big Pharma Used Strippers, Guns, and Cash to Push Opioids
 
25:25
“Behave More Sexually:” How Big Pharma Used Strippers, Guns, and Cash to Push Opioids: . Thanks for watching, subscribe for more videos: https://www.youtube.com/channel/UCD-dZKUYn4wYK9zOKg-xRcQ?sub_confirmation=1 Mother Jones; GeorgePeters/Getty Images Around 2015, just before overdoses sweeping the country started making national news, a pharmaceutical sales representative in New Jersey faced a dilemma: She wanted to increase her sales but worried that the opioid painkiller she was selling was addictive and dangerous. The medication was called Subsys, and its key ingredient, fentanyl, is a synthetic opioid 100 times stronger than morphine. When the rep, who requested to go by her initials, M.S., voiced her concerns to her manager, she was told that Subsys patients were “already addicts and their prospects were therefore essentially rock-bottom,” according to a recently unsealed whistleblower lawsuit that M.S. filed after leaving Insys in 2016. To boost her numbers, the manager allegedly advised M.S. to “behave more ually toward pain-management physicians, to stroke their hands while literally begging for prescriptions,” and to ask for the prescriptions as a “favor.” The lawsuit details dubious sales tactics: taking doctors to strip clubs, paying kickbacks for more prescriptions, posing as doctors’ representatives in order to get insurance to cover the drug. These days, fentanyl makes headlines for driving the overdose epidemic: The opioid is often illicitly produced and mixed with heroin or other drugs. But Subsys, made by pharmaceutical company Insys, is one of a handful of potent, highly regulated prescription fentanyl brands specifically intended for cancer patients suffering from “breakthrough pain,” episodes of extreme pain that arise despite other painkillers the patients are taking around the clock. Since Subsys gained approval from the Food and Drug Administration in early 2012, Insys’ growth has been meteoric. In the spring of 2013, the company went public; by the end of the year, it was the nation’s best-performing IPO. By 2015, revenue from Subsys was approaching $500 million.   All the while, a handful of Insys employees were quietly filing whistleblower lawsuits, unbeknown to each other, alleging that the addictive drug was marketed to patients who suffered from all kinds of pain—not just cancer patients with breakthrough pain—and detailing dubious sales tactics: taking doctors to strip clubs, paying kickbacks for more prescriptions, posing as doctors’ representatives in order to get insurance to cover the drug. In the so-called qui tam lawsuits, whistleblowers file cases under seal on behalf of the US government, which investigates the allegations over the course of months or years as it decides whether to intervene and pursue a civil case.  In May, the Department of Justice announced it was intervening, consolidating M.S.’s complaint with four other whistleblower cases filed between 2013 and 2016. The announcement resulted in the unsealing of the five complaints, opening the floodgates to hundreds of pages of court documents that offer a rare glimpse into the lengths that the pharmaceutical company went to market and sell Subsys. Four #“BehaveMoreSexually, #PharmaUsedStrippersGuns, #Cash, #PushOpioids
Просмотров: 1 puatwhsi Mahdiao
FreshEmailDatabase 2018
 
01:14
So you're a businessman and you want to run a successful business but getting in touch with the right customers it's not as easy as you thought it was as the conversion rates of your sales team but it rock bottom because they arn't contacting the right people you have two options you can either spend ages and creating a list of valuable contacts who would be interested in your service or you can logon to www.freshemaildatabase.com and simply buy the email database of you the target customers from us it's a no-brainer whether you own a pharmaceutical company or a jewelry retail business we can get you the golden lists that can increase your conversion rates , our databases are always up to date with the latest email address his phone numbers contact info and many other forms of contact info there or even categorically organized for your convenience just log onto logon to www.freshemaildatabase.com instantly purchase and download a male databases that can optimize your marketing strategy
Просмотров: 2 latest Indian viral sensation